Search Details

Word: bottomly (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...would anybody put feet on a phone?" Ive has the answer, of course: "It raises the speaker on the back off the table. But the right solution is to put the speaker in the right place in the first place. That's why our speaker isn't on the bottom, so you can have it on the table, and you don't need feet." Sure enough, no feet toe the iPhone's smooth lines...

Author: /time Magazine | Title: Apple's New Calling: The iPhone | 1/10/2007 | See Source »

...people around the world but also how green businesses will be a fundamental engine of change in the 21st century. In his first column, Bryan Walsh, our Tokyo bureau chief, argues that companies have converted to environmentalism not out of a sense of virtue but because it helps the bottom line...

Author: /time Magazine | Title: A Changing TIME | 1/6/2007 | See Source »

...sustainable seafood--Wal-Mart could help start a green wave across the U.S. economy, especially among smaller companies that might be less eager or able to change on their own. "When Wal-Mart talks, everyone listens," says Andrew Savitz, an environmental business consultant and the author of The Triple Bottom Line...

Author: /time Magazine | Title: How Business Saw the Light | 1/5/2007 | See Source »

Wasn't it expensive? Yes, but we paid at the bottom of the range for these assets. Within four to five years about 25% of our sales will be from digital media, and this operation will seem very cheap...

Author: /time Magazine | Title: 10 Questions For Maurice Lévy | 1/4/2007 | See Source »

...bottom line isn't the only culprit. It does take on average more than 13 years and often several hundred million dollars for a company to research and test a major new drug before it's presented to the FDA for approval. Only about one of every 10,000 chemical compounds that are first tested end up as medicine cleared by the feds. Converting basic scientific research into effective medicines to treat complex diseases like cancer has also become more difficult the past several years with more expensive and longer drug trials, as well as higher failure rates. There...

Author: /time Magazine | Title: Too Little Bang for the Buck in Drug Research? | 12/27/2006 | See Source »

Previous | 302 | 303 | 304 | 305 | 306 | 307 | 308 | 309 | 310 | 311 | 312 | 313 | 314 | 315 | 316 | 317 | 318 | 319 | 320 | 321 | 322 | Next